| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.59B | 41.27B | 40.01B | 41.43B | 39.64B | 37.50B |
| Gross Profit | 10.24B | 10.62B | 10.31B | 10.57B | 9.96B | 9.78B |
| EBITDA | 2.19B | 2.47B | 2.27B | 2.82B | 2.66B | 2.41B |
| Net Income | 490.00M | 744.00M | 597.00M | 1.22B | 1.16B | 855.00M |
Balance Sheet | ||||||
| Total Assets | 38.60B | 39.10B | 38.71B | 36.73B | 34.46B | 34.15B |
| Cash, Cash Equivalents and Short-Term Investments | 3.39B | 3.93B | 4.83B | 4.37B | 5.05B | 4.47B |
| Total Debt | 7.59B | 7.13B | 7.26B | 4.99B | 2.83B | 3.38B |
| Total Liabilities | 18.62B | 18.30B | 18.88B | 17.27B | 16.76B | 17.17B |
| Stockholders Equity | 19.78B | 20.60B | 19.67B | 19.36B | 17.62B | 16.99B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 39.00M | -1.35B | -2.17B | 1.51B | 865.00M |
| Operating Cash Flow | 0.00 | 1.87B | 214.00M | -284.00M | 2.42B | 1.93B |
| Investing Cash Flow | 0.00 | -1.97B | -1.45B | -2.02B | -786.00M | -1.06B |
| Financing Cash Flow | 0.00 | -836.00M | 1.50B | 1.62B | -1.11B | -998.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥17.11B | 10.79 | ― | 3.50% | -1.36% | 5.14% | |
74 Outperform | ¥28.98B | 16.01 | ― | 4.46% | -4.23% | -1.63% | |
68 Neutral | ¥9.87B | 11.77 | ― | 3.73% | ― | ― | |
65 Neutral | ¥4.53B | 11.16 | ― | 2.53% | -18.59% | -22.05% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
45 Neutral | ¥43.34B | 26.60 | ― | 1.60% | 10.90% | ― | |
43 Neutral | ¥16.23B | -2.58 | ― | 5.45% | -2.22% | 18.80% |